FMD Clinical Trial
Official title:
Effects of Five Days of Physical Inactivity on Endothelial Function in Healthy Humans
NCT number | NCT04199949 |
Other study ID # | A90355 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | November 1, 2018 |
Est. completion date | March 1, 2020 |
Verified date | February 2022 |
Source | University of Nottingham |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Physical inactivity is a significant predictor of major non-communicable diseases such as type 2 diabetes (7%), cardiovascular disease (6%), musculoskeletal disorders and some types of cancer, and has been proposed to be the 4th leading cause of death worldwide. The investigators aim is to assess the vascular (endothelial) function before and after a 5-day period of reduced activity of upper and lower limbs via an arm sling and daily step counts reduction, respectively, in healthy participants. Twelve young (ages of 18 - 35 years), healthy, males and females, recreationally active with a body mass index between 18 and 27 kg/m2 will be recruited. The participants will then randomly undergo two 5-day interventions: (A) 5 consecutive days of habitual daily levels of physical activity and matched food intake (Control trial). (B) 5 consecutive days of reduced step count by 80% compared to the Control trial combined with their non-dominant arm placed in a sling and a reduction in food (energy) intake (~20%) to match the reduction in energy expenditure induced by inactivity (Inactivity trial). On days 1 and 6 of each experimental trial, the endothelial function of the brachial and popliteal arteries, and hand grip strength will be measured.
Status | Completed |
Enrollment | 8 |
Est. completion date | March 1, 2020 |
Est. primary completion date | March 1, 2020 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Male |
Age group | 18 Years to 35 Years |
Eligibility | Inclusion Criteria: - Non-smoking - Males - Age (18-35 years old) - Body mass index (BMI) of 18-27 kg/m2 - Recreationally active - Ability to give informed consent Exclusion Criteria: - Smoking - Any metabolic (e.g. diabetes), endocrine (e.g. hyperthyroidism) or cardiovascular (e.g. heart or blood) abnormalities including hypertension or heart failure - Clinically significant abnormalities on screening including ECG abnormalities - Taking routine medication that may alter cardiovascular function and blood flow (e.g. blood pressure-lowering drugs or drugs that cause hypertension) - Well-trained individuals - On an energy-restricted diet or seeking to lose weight - High alcohol consumption (<3-4 units/day) |
Country | Name | City | State |
---|---|---|---|
United Kingdom | The University of Nottingham | Nottingham | Nottinghamshire |
Lead Sponsor | Collaborator |
---|---|
University of Nottingham |
United Kingdom,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Change from baseline of flow-mediated vasodilatation (FMD) of the brachial artery | The FMD of the brachial artery will be measured using an ultrasound collected at baseline and continuously for 80 seconds post-arm occlusion for 5 minutes | Over 6 minutes and 20 seconds on day 1 and day 6 of each study arm | |
Primary | Change from baseline of flow-mediated vasodilatation (FMD) of the popliteal artery | The FMD of the popliteal artery will be measured using an ultrasound collected at baseline and continuously for 80 seconds post-arm occlusion for 5 minutes | Over 6 minutes and 20 seconds on day 1 and day 6 of each study arm | |
Secondary | Hand grip strength | The hand grip strength will be measured using a hand dynamometer. Three maximum hand grips separated by one minute rest at the end of each visit. | 3 minutes |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT02127333 -
Role of Oxygen for Vascular Dysfunction
|
N/A | |
Completed |
NCT05857085 -
Novel Therapeutics and Endothelial Dysfunction in T1DM Patients
|
Phase 4 | |
Recruiting |
NCT05747924 -
Phase 1/2 Study of AOC 1020 in Adults With Facioscapulohumeral Muscular Dystrophy (FSHD)
|
Phase 1/Phase 2 | |
Completed |
NCT01862146 -
Arterial Remodeling in Smokers
|
N/A |